Jessica Bordini
Via Olgettina 58
Milan, 20132, Italy
Milan, 20132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
HS1 loss drives cytoskeletal dysregulation and reduces sensitivity to BTK inhibition in chronic lymphocytic leukemia.
Journal: Journal of leukocyte biology
Published: February 04, 2026
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies.
Journal: Journal of hematology & oncology
Published: October 27, 2025
The deubiquitinase activity of CYLD is required for B cell differentiation.
Journal: Cell death & disease
Published: August 07, 2025
Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia.
Journal: Hematology/oncology clinics of North America
Published: July 17, 2025
Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.
Journal: American journal of hematology
Published: November 23, 2023
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death.
Journal: Cell death & disease
Published: October 23, 2023
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia.
Journal: Leukemia
Published: July 04, 2023
PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target.
Journal: Journal of cellular and molecular medicine
Published: December 05, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection.
Journal: JCI insight
Published: June 08, 2021
Last Updated: 09/26/2026